Polyglutamine Induced Misfolding of Huntingtin Exon1 is Modulated by the Flanking Sequences

Abstract

Polyglutamine (polyQ) expansion in exon1 (XN1) of the huntingtin protein is linked to Huntington's disease. When the number of glutamines exceeds a threshold of approximately 36–40 repeats, XN1 can readily form amyloid aggregates similar to those associated with disease. Many experiments suggest that misfolding of monomeric XN1 plays an important role in the length-dependent aggregation. Elucidating the misfolding of a XN1 monomer can help determine the molecular mechanism of XN1 aggregation and potentially help develop strategies to inhibit XN1 aggregation. The flanking sequences surrounding the polyQ region can play a critical role in determining the structural rearrangement and aggregation mechanism of XN1. Few experiments have studied XN1 in its entirety, with all flanking regions. To obtain structural insights into the misfolding of XN1 toward amyloid aggregation, we perform molecular dynamics simulations on monomeric XN1 with full flanking regions, a variant missing the polyproline regions, which are hypothesized to prevent aggregation, and an isolated polyQ peptide (Qn). For each of these three constructs, we study glutamine repeat lengths of 23, 36, 40 and 47. We find that polyQ peptides have a positive correlation between their probability to form a β-rich misfolded state and their expansion length. We also find that the flanking regions of XN1 affect its probability to^x_page_count=28 form a β-rich state compared to the isolated polyQ. Particularly, the polyproline regions form polyproline type II helices and decrease the probability of the polyQ region to form a β-rich state. Additionally, by lengthening polyQ, the first N-terminal 17 residues are more likely to adopt a β-sheet conformation rather than an α-helix conformation. Therefore, our molecular dynamics study provides a structural insight of XN1 misfolding and elucidates the possible role of the flanking sequences in XN1 aggregation.

Substrate Recognition in Nuclear Protein Quality Control Degradation Is Governed by Exposed Hydrophobicity That Correlates with Aggregation and Insolubility

“…From these results, we suspected that the hydrophilic linker sequence positioned near the hydrophobic residue stretch could influence the strength of the hydrophobic residues and mitigate the effect of hydrophobicity, which would alter the ability of San1 to recognize its substrates. In support of this hypothesis, flanking sequences to aggregation-prone regions have been shown to influence protein aggregation (41)(42)(43)(44)(45)(46)(47).…”

Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington’s disease

“…Using the associative memory, water-mediated interactions, structure and energy model (AWSEM), previous simulations by our group have successfully explained how the change of critical nucleus size arises from the differences in the propensity of monomeric polyQ repeats of different lengths to form β-hairpins: the longer repeats fold into hairpins intramolecularly before they aggregate (9). The aggregation of the diseasecausing peptide is, however, further complicated by the presence of flanking amino acid sequences in fragments encoded by HTT exon 1. Experiments indicate that the addition of NT17 at the N terminus of polyQ enormously accelerates the aggregation, probably by encouraging the formation of prefibrillar oligomers (10)(11)(12)(13)(14)(15)(16), whereas the addition of the proline-rich region at the C terminus decreases the rate of aggregation apparently without changing fundamentally the mechanism (10,16,17). Structural characterization of the aggregates (13,14,(18)(19)(20) has shown that, even when there are flanking sequences, polyQ remains the fiber core and adopts a β-hairpin conformation.…”

Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice

“…The most dramatic effects have been described for huntingtin phosphorylation at serine 13 and serine 16. These two amino acid residues are part of the highly conserved amino-terminal "N17" domain of huntingtin, a domain that regulates huntingtin intracellular localization and association to cellular membranes (12, 13), as well as kinetics of mutant huntingtin aggregation (14,15). Phosphomimetic mutations of serine 13 and serine 16 by aspartic or glutamic acid substitution (S13D and S16D or S13E and S16E) decrease the toxicity of mutant huntingtin fragments in vitro (10, 16).…”